title: Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate.
authors.forename: Grigorios S
authors.initials: GS
authors.lastname: Karagiannidis
authors.forename: Marina
authors.initials: M
authors.lastname: Mantzourani
authors.forename: John
authors.initials: J
authors.lastname: Meletis
authors.forename: Amalia N
authors.initials: AN
authors.lastname: Anastasopoulou
authors.forename: George A
authors.initials: GA
authors.lastname: Vaiopoulos
mesh_terms: D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage; D000981:Antiprotozoal Agents / Q000008:administration & dosage; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy; D005221:Fatigue / Q000209:etiology; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006529:Hepatomegaly / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007891:Leishmania / Q000302:isolation & purification*; D007898:Leishmaniasis, Visceral / Q000150:complications* / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use*; D013163:Splenomegaly / Q000209:etiology; D014057:Tomography, X-Ray Computed
chemical_list: D000981:Antiprotozoal Agents; D007166:Immunosuppressive Agents; D000666:Amphotericin B; D008727:Methotrexate